BIIB057 in Subjects With Rheumatoid Arthritis and Inadequate Response to Disease-Modifying Antirheumatic Drugs
Status:
Withdrawn
Trial end date:
2014-03-01
Target enrollment:
Participant gender:
Summary
Phase II study designed to evaluate the safety and efficacy of BIIB057 in Subjects with
Rheumatoid Arthritis who have experienced an Inadequate Response to Disease-Modifying
Antirheumatic Drugs (DMARDs).